Acadian Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Acadian Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,146,905	Closed	-$12.1M	–	1742
2017 Q1	$12.1M	Buy	1,146,905 +829,326	+261%	+$8.02M	0.06%	256
2016 Q4	$2.67M	Buy	317,579 +292,297	+1,156%	+$2.29M	0.01%	531
2016 Q3	$181K	Buy	+25,282	New	+$176K	﹤0.01%	984
2015 Q3	–	Sell	-58,630	Closed	-$623K	–	1537
2015 Q2	$623K	Sell	58,630 -35,539	-38%	-$416K	﹤0.01%	762
2015 Q1	$1.17M	Buy	+94,169	New	+$1.04M	0.01%	632
2014 Q1	–	Sell	-9,157	Closed	-$113K	–	1121
2013 Q4	$113K	Hold	9,157	–	–	﹤0.01%	864
2013 Q3	$79K	Hold	9,157	–	–	﹤0.01%	838
2013 Q2	$80K	Buy	+9,157	New	+$81.9K	﹤0.01%	757

Other funds holding ELOS

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Acadian Asset Management's ELOS Position: Q2 2017 in Review

Acadian Asset Management sold out of Syneron Medical Ltd (ELOS) in Q2 2017, closing a stake of 1,146,905 shares — an estimated $12.1M sold.

Acadian Asset Management first reported a position in ELOS in Q2 2013 and held it in 8 quarters. The position peaked at $12.1M in Q1 2017. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2017.

Acadian Asset Management reported no remaining Syneron Medical Ltd position as of Q2 2017 after selling out during the quarter.
Acadian Asset Management sold 1,146,905 Syneron Medical Ltd shares in Q2 2017, an estimated $12.1M.
Acadian Asset Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 8 quarters.
Acadian Asset Management's Syneron Medical Ltd position peaked at $12.1M in Q1 2017.
79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2017.

Based on Acadian Asset Management's 13F filing for Q2 2017, filed 25 Jul 2017.